Open access
Sep 2026
Conserved roles of cardiac endothelial ETS factors in ventricular development and disease
L. Wang, A. Schroeder, K. Marchetti et al.
· medRxiv · 0 citations
We have 2 of 131 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Open access
Aug 2026
Rigosertib Reverses Hypertrophic Cardiomyopathy in Noonan Syndrome
It is suggested rigosertib normalizes and reverses RASopathy-associated HCM and other NS-associated syndromic features, supporting its development as a promising treatment for RAF1-associated HCM and, potentially, other RASopathy-dependent pathologies.
Levi Legler, K. Marchetti, Bing Xu et al.
· Circulation · 0 citations